These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19374879)
1. Suppression of T-cell response and prolongation of allograft survival in a rat model by tryptophan catabolites. Dai X; Zhu BT Eur J Pharmacol; 2009 Mar; 606(1-3):225-32. PubMed ID: 19374879 [TBL] [Abstract][Full Text] [Related]
2. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Bauer TM; Jiga LP; Chuang JJ; Randazzo M; Opelz G; Terness P Transpl Int; 2005 Jan; 18(1):95-100. PubMed ID: 15612990 [TBL] [Abstract][Full Text] [Related]
3. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation. Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines. Weber WP; Feder-Mengus C; Chiarugi A; Rosenthal R; Reschner A; Schumacher R; Zajac P; Misteli H; Frey DM; Oertli D; Heberer M; Spagnoli GC Eur J Immunol; 2006 Feb; 36(2):296-304. PubMed ID: 16385630 [TBL] [Abstract][Full Text] [Related]
5. Tryptophan metabolite 3-hydroxyanthranilic acid selectively induces activated T cell death via intracellular GSH depletion. Lee SM; Lee YS; Choi JH; Park SG; Choi IW; Joo YD; Lee WS; Lee JN; Choi I; Seo SK Immunol Lett; 2010 Aug; 132(1-2):53-60. PubMed ID: 20570696 [TBL] [Abstract][Full Text] [Related]
6. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. López AS; Alegre E; LeMaoult J; Carosella E; González A Mol Immunol; 2006 Jul; 43(14):2151-60. PubMed ID: 16490253 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic T-cell apoptosis induced by interleukin-10-modified dendritic cells: a mechanism of prolongation of intestine allograft survival? Zhu M; Wei MF; Liu F; Shi HF; Wang G; Chen S Transplant Proc; 2004 Oct; 36(8):2436-7. PubMed ID: 15561271 [TBL] [Abstract][Full Text] [Related]
8. A novel chemical compound, NK026680, targets dendritic cells to prolong recipient survival after rat liver grafting. Hara Y; Funeshima-Fuji N; Fujino M; Tokunaka K; Abe F; Sato Y; Hatakeyama K; Takahara S; Ezaki T; Kimura H; Li XK Transplantation; 2007 Aug; 84(3):407-14. PubMed ID: 17700168 [TBL] [Abstract][Full Text] [Related]
9. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival. Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus. Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. Terness P; Bauer TM; Röse L; Dufter C; Watzlik A; Simon H; Opelz G J Exp Med; 2002 Aug; 196(4):447-57. PubMed ID: 12186837 [TBL] [Abstract][Full Text] [Related]
12. Astilbin suppresses acute heart allograft rejection by inhibiting maturation and function of dendritic cells in mice. Zou S; Shen X; Tang Y; Fu Z; Zheng Q; Wang Q Transplant Proc; 2010 Nov; 42(9):3798-802. PubMed ID: 21094859 [TBL] [Abstract][Full Text] [Related]
13. Effect of streptavidin on cardiac allograft prolongation is due to host T-Cell suppression. Witkowski P; Fawwaz RA; Jin MX; DePaz HA; Oluwole OO; Hardy MA; Oluwole SF Transplant Proc; 2005; 37(1):116-8. PubMed ID: 15808566 [TBL] [Abstract][Full Text] [Related]
14. Prolongation of rat intestinal allograft survival by administration of triptolide-modified donor bone marrow-derived dendritic cells. Chen T; Xu H; Wang HQ; Zhao Y; Zhu CF; Zhang YH; Ji MJ; Hua YB; Wu WX Transplant Proc; 2008 Dec; 40(10):3711-3. PubMed ID: 19100471 [TBL] [Abstract][Full Text] [Related]
15. The tryptophan metabolite 3-hydroxyanthranilic acid suppresses T cell responses by inhibiting dendritic cell activation. Lee WS; Lee SM; Kim MK; Park SG; Choi IW; Choi I; Joo YD; Park SJ; Kang SW; Seo SK Int Immunopharmacol; 2013 Nov; 17(3):721-6. PubMed ID: 24029595 [TBL] [Abstract][Full Text] [Related]
16. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking. Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521 [TBL] [Abstract][Full Text] [Related]
17. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models. Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410 [TBL] [Abstract][Full Text] [Related]
18. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells. Xu DL; Liu Y; Tan JM; Li B; Zhong CP; Zhang XH; Wu CQ; Tang XD Scand J Immunol; 2004 Jun; 59(6):536-44. PubMed ID: 15182248 [TBL] [Abstract][Full Text] [Related]
19. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat. Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of the immunosuppressive effect in vivo of novel immunosuppressive drug beta-SQAG9, which inhibits the response of the CD62L+ T-cell subset. Takenouchi M; Sahara H; Yamamoto Y; Matsumoto Y; Imai A; Fujita T; Tamura Y; Takahashi N; Gasa S; Matsumoto K; Ohta K; Sugawara F; Sakaguchi K; Jimbow K; Sato N Transplant Proc; 2005; 37(1):139-42. PubMed ID: 15808574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]